Aclarion, Inc. is a healthcare technology company that focuses on leveraging advanced imaging and machine learning to enhance the assessment and treatment of chronic pain conditions. By utilizing proprietary algorithms and data analysis techniques, the company aims to improve patient outcomes through more accurate diagnostics and personalized treatment plans. Aclarion seeks to transform the way healthcare providers approach pain management by integrating innovative solutions that combine clinical expertise with cutting-edge technology, ultimately leading to better quality of care for patients suffering from debilitating pain. Read More
The company said demand for Nociscan continued to accelerate through 2025, with scan volumes rising sharply across the U.S., the U.K., and Europe as new imaging centers and physician users came onboard.
A look at the top 20 most-searched stocks on Benzinga Pro in March. While many had news in the month that could affect rankings, the trends could be a sign of what's to come.
Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.
